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1. Introduction
  Chikungunya virus (CHIKV), a reemerging arboviral 
infection belongs to the genus Alphavirus, family 
Togaviridae is an enveloped virus containing positive sense 
single stranded RNA as its genetic material. It is about 
11 805 nucleotides in length containing two open reading 
frames of about 7 422(non structural genes: nsP1-nsP4) 
and 3 744(Structural genes: C, E3, E2, 6K, E1) nucleotides 
in length. The Alphavirus genus consists of 29 species 
of arboviruses that have been classified into 7 antigenic 
complexes: Barmah Forest (BF), Eastern equine encephalitis 
(EEE), Middelburg (MID), Ndumu (NDU), Semliki Forest 
(SF), Venezuelan equine encephalitis (VEE), and Western 
equine encephalitis (WEE). Chikungunya virus belongs 
to Semiliki Forest virus antigenic complex and is usually 
characterized by fever, arthralgia and myalgia[1]. Meningo-
encephalitis, meningo encephalo myeloradiculitis, 
myeloradiculitis, myelitis, myeloneuropathy, Guillain-
Barre syndrome, external opthalmoplegia, facial palsy, 
sensorineural hearing loss and optic neuritis are the various 
neurological complications observed during the recent 
CHIKV outbreak[2]. It is transmitted by Aedes aegyptii 
and Aedes albopictus mosquitoes. Aedes albopictus played 
a pivotal role in transmitting the CHIKV in the recent 
outbreaks of Reunion islands, North Eastern Italy and 
India[3-5]. CHIKV epidemic was first reported from Makonde 
plateau, Tanzania during 1952-1953 followed by numerous 
outbreaks in South Africa, Congo, Zimbabwe, Uganda, 
Zambia, Senegal, Nigeria, Angola[6-8]. First outbreak in 
India of CHIKV was reported in 1963 in Kolkata followed 
by epidemics in Chennai, Pondicherry and Vellore in 1964; 
Vishakapatnam, Rajmundry, Kakinada, Nagpur in 1965; 
and Barsi in 1973[9]. Phylogenetic analysis based on partial 
E1 gene sequences showed the presence of three distinct 
CHIKV phylogroups. The first phylogroup contained all 
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isolates from West Africa; the second phylogroup involved 
isolates from Central, East and South Africa (CESA); and the 
third phylogroup contained Asian isolates. Until 2006 these 
three genotypes were restricted to their geographical areas. 
Earlier outbreaks in India were due to Asian genotype. 
The present outbreak in Indian Ocean islands, India were 
attributed to be of CESA genotype[9-12]. The reemergence 
of CHIKV in Malaysia provided evidence of co-circulation 
of different genotypes in the same geographical area[13, 14]. 
Chikungunya has emerged as an important arboviral disease 
of public health concern, by which approximately 7.5 million 
people were victimized over a period of 5 years[15]. It has 
been declared as a high priority pathogen by NIH[16]. Two 
hundred and sixteen districts in India were affected by 
CHIKV infections with  an estimate of 1.38 million people 
being victimized by the end of 2006 and which further 
declined to an estimated 59 535, 95 091 and 68 245 cases by 
the end of 2007, 2008 and 2009, respectively [17,18]. Andhra 
Pradesh, the most affected state was first to report the 
CHIKV epidemic in December 2005 in India[19]. Blood group, 
age and gender are found to be associated with the status 
of CHIKV. It is observed that the Rh positive individuals 
are more susceptible when compared to their Rh negative 
counterparts in acquiring CHIKV disease[20]. In some recent 
studies higher CHIKV infection rates were observed in males 
compared to their female counterparts and differential 
exposure to Aedes albopictus mosquitoes is supposed to be 
the plausible reason[20-22]. Mutations in CHIKV genome, 
enhanced efficiency of mosquitoes to transmit CHIKV, 
immunologically naive population, rapid means of trade and 
travel, global warming and lack of  public health system are 
some of the important factors influencing the re-emergence 
of CHIKV[23].
  Due to similarity in symptoms with other viral, bacterial 
and parasitic diseases differential diagnosis of CHIKV plays 
an important role[24]. RT-PCR, Real time PCR and RT LAMP 
are some of the techniques used for early detection of CHIKV 
during acute phase of infection. In the present study we 
carried out survey and screening of areas having CHIKV 
suspected fever. We characterized the causative agent, 
identified the circulating CHIKV genotype and scrutinized 
into the mutations prevalent in the circulating CHIKV strains 
of the present study.  
2. Materials and methods
2.1. Study area and sample collection
  In March and April of 2008, the Mobile Medical Unit 
Office, Kadapa district, Andhra Pradesh observed a huge 
influx of patients to the Primary Health Center (PHC) with 
crippling arthralgia and fever in Kokkarayapalli village. 
Similar fever cases with arthralgia were observed in different 
places of Kadapa district. A survey was carried out from 
March 2008-April 2009; in different places of kadapa district 
and blood samples from patients exhibiting symptoms 
compatible with CHIKV infection were collected. Prior to 
sample collection ‘Informed oral consent’ were obtained 
from all the patients and their parents (in case of minors). 
The details of the areas surveyed are furnished in Figure 1. 
Details of the clinical samples processed during the present 
study are furnished in Table 1.  Samples were collected in 
sterile vials without anticoagulant, transported in coolant 
packs and stored at 4 曟 till use. All samples were processed 
within 24 hours after the collection. 
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Figure 1. Map of Andhra Pradesh showing the location of sample 
collection areas (●).
1. Sannapalle, 2. Thudumuladinne, 3. Dadireddipalle, 4. Kamalapuram, 
5. Pedda Putha, 6. Kokkarayapalle, 7. Chennur, 8. Cuddapah, 9. Galivedu,
10. Rayachoti, 11. Rajampet, 12. Kattaguttapalle, 13. Chinnamandem, 
14. Yeguvarajugaripalle, 15. Diguvarajugaripalle, 16. Kodur. 
2.2. RNA extraction and RT-PCR
  RNA was extracted from 250 毺L of serum samples 
according to the manufacturer’s instructions (TRI Reagent® 
BD Sigma-Aldrich, USA), the pellets were dissolved in 
nuclease free water and stored at -20 曟 till use. cDNA was 
synthesized in 20 毺L reaction volume using Oligo (dT) primer. 
A primer pair DVRChk-F/DVRChk-R targeting 330 bp 
fragment of E1 gene was used for screening of CHIKV 
suspected acute phase blood samples[11]. PCR amplification 
was carried out in 50 毺L of reaction volume containing 
3 毺L of cDNA, 10 pmol of forward primer (DVRChk-F:5!-
ACCGGCGTCTACCCATTCATGT-3!), 10 pmol of reverse primer 
(DVRChk-R 5!-GGGCGGGTAGTCCATGTTGTAGA-3!), 2 mM 
MgCl2 (Fermentas, USA), 2.5 Units of Taq DNA polymerase 
(Fermentas, USA) 0.2 mM each of dNTPs (Fermentas, USA) 
and nuclease free water. The reaction was carried out using 
gradient thermal cycler (Corbett Research, Model CG1-96, 
Australia) and the PCR amplification conditions included 
an initial denaturation cycle at 94 曟 for 5 min followed by 
35 cycles of denaturation for 45 sec at 94 曟, annealing for 
30 sec at 56 曟 and extension for 1 min at 72 曟. A final 
extension step of 15 min at 72 曟 was carried out at the end 
and the PCR products along with the Marker DNA (100 bp 
DNA ladder, Fermentas, USA) were electrophoresed in 2 % 
agarose gel.
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2.3. CHIK IgM rapid tests
  The convalescent phase serum samples were tested for 
CHIKV specific antibodies using SDBioline Chikungunya 
IgM Rapid Tests according to manufacturer’s instructions. 
2.4. Cloning, nucleotide sequencing and sequence analysis
  Four of the above study strains were gel extracted using 
the Qiaquick gel extraction kit (Qiagen, USA) and then 
cloned into pTZ57R/T vector (Fermentas, USA) according to 
the Manufacturer’s instructions. The resulting recombinant 
plasmids were transformed into Escherichia coli DH5 毩 cells 
and the recombinant clones were selected by blue white 
colony selection. The positive clones were sequenced using 
M13 universal primers at commercial sequencing facility 
(Eurofins Genomics India Pvt Ltd, Bangalore). Multiple 
sequence alignments were done using Bioedit software (USA) 
and the generated alignments were used to determine the 
percentage of homologies between the sequences. Neighbour 
Joining algorithm was used to construct phylogenetic trees 
by the use of MEGA version 4.0 (bootstrap analysis with 1 000 
replication) using O’nyong nyong virus (AF079456) as the out 
group. 
2.5 Statistical analysis
  The percentage of CHIKV infection was calculated by 
dividing the number of CHIKV positive samples by total 
number of samples. For observing the statistical significance 
Chi square test (χ2) has been performed and a P value of 
< 0.05 was considered significant.
3. Results  
  In this cohort, patients with severe fever, joint pains, 
myalgia and headache which are the characteristics 
features of CHIKV infections were observed during our 
epidemiological surveys. In total 467 CHIKV suspected 
samples were collected from various places in kadapa 
district of Andhra Pradesh during March 2008-April 
2009. As malaria is endemic in Eguvarajugaripalli and 
Diguvarajugaripalli villages, the DMHO staff tested the 
patients and found that all the samples were negative for P. 
falciparum. Later on these samples were tested for CHIKV. 
CHIKV specific RNA was detected from clinical samples 
up to 7th day after the onset of the disease. A total of 149 
(54.18%) serum samples were found positive for the presence 
of CHIKV gene specific 330 bp amplicon (Figure 2). 192 
convalescent phase serum samples were screened by CHIK 
IgM rapid tests for the presence of IgM and IgG anti CHIKV 
antibodies. The serological investigation revealed the 
presence of anti CHIK IgM in 104 samples (54.16%) and anti-
CHIK IgM and IgG in 21 patients (10.93%). The statistical 
significance between the CHIKV diagnostic tests (RT-PCR 
and IgM strip analysis) and CHIKV suspected samples was 
observed using Chi square test statistic and was found to be 
statistically significant (Chi-Square: 5.121 2; *P<0.05). Hence 
it is concluded that the CHIKV diagnostic tests played an 
important role in confirming CHIKV infections. The possible 
role of viremic people in these villages coupled with rapid 
means of transportation facility in spreading CHIKV to 
neighbouring places cannot be underestimated.  Four 
clinical strains (CHIK-Kadapa; CHIK- Kamalapuram; CHIK-
Kattaguttapalli and CHIK-AP-KDP) were selected, cloned, 
sequenced and deposited to Genbank DNA database under 
the accession numbers: GQ119362, GQ119363, GQ119364 
and FJ225403. In order to determine the phylogroup of the 
circulating CHIKV strains of the present study a 303 bp 
region of E1 gene of the present study strains (region 10 213 bp-
105 15 bp corresponding to AM258990) were compared with 
17 other CHIKV isolates corresponding to 3 different CHIKV 
genotypes. Phylogenetic analysis showed that all the 4 
CHIKV strains (Present study) from India, detected during 
2008-2009 grouped into CESA genotype and clustered in 
a distinct lineage (Figure 3). This lineage showed close 
relationship to the Reunion 2005, 2006 strains (AM258990, 
DQ443544) showing the possible evolution of the Indian 
strains from Reunion Outbreak. Comparative homology 
analysis of “CHIK-Kadapa” strain (GQ119362) revealed 
(99.23依 0.52) % and 100 % of homology at nucleotide and 
amino acid level respectively with CESA isolates. Percent 
homology of CHIK-Kadapa strain (GQ119362) with different 
CHIKV isolates is furnished in Table 2. The alignment of 
the common region of the sequences (deduced amino acids) 
of the present study strains with the reference strains of 
CHIKV is given in Figure 4(region 10 186 bp -10 515  bp 
corresponding to AM258990). In total 28 synonymous 
mutations and 2 non synonymous mutations were observed 
in the present study strains, details of which are furnished 
in Table 3. Six mutations, viz. A306G, C384T, T519C, C531T, 
T552C and C555T found consistently in all the four CHIKV 
strains of the present study were synonymous mutations. 
C503T nucleotide change in CHIK-AP-KDP strain (FJ225403) 
and A548T change in CHIK-Kattaguttapalli strain (GQ119364) 
resulted in non synonymous mutations S168L and D183V 
respectively.  
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Figure 2. Gel photograph showing 330 bp of E1 gene of Chikungunya 
virus by reverse transcriptase-polymerase chain reaction. 
Lane M: 100 bp marker; Lane 1, 2, 3, 5, 6, 8, 9: 330 bp amplicon of 
E1 gene from clinical samples; Lane 4, 7 CHIKV negative samples.
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Figure 3. Phylogenetic tree constructed from the alignment of partial E1 gene amino acid sequences of the present study strains with those of 
other reported CHIKV sequences taking ONN as an out group. 
The present study strains grouped with the isolates of Central East South African genotype. Taxa marked in “●” indicate the present study 
strains. The values at the forks indicate the number of trees that this grouping occurred after bootstrapping the data. The scale bar shows the 
number of substitutions per base.
Table 1 
Details of clinical samples processed during the present study.
Place Sampling time
CHIKV suspected samples
Acute phase samples*
(149/275)
Convalescent phase samples#
(125/192)
Chennur March 2008 0/4 0/1
Kokkarayapalli March 2008 39/55   9/17
Kodur June 2008 13/27   7/19
Yeguvarajugari palle  and Diguvarajugari palle July 2008 2/3 29/30
Rajampeta September 2008 18/ 39   9/21
Thudumaladinne October 2008 11/16 7/8
Sannapalle October 2008 5/8 2/3
Dadireddy Palle December 2008 5/7 3/8
Kamalapuram January 2009 4/9 21/21
Kattagutta Palli February 2009   3/12 7/7
Kadapa town February 2009 19/37  8/12
Pedda Putha  March 2009 3/8 4/4
Rayachoti March 2009 18/35 13/31
Galivedu April 2009 2/5 3/7
Chinnamandem April 2009   7/10 3/3
* Screened by RT-PCR, Acute phase samples= No. of samples positive/No. of samples tested; # Screened by CHIK IgM strips, Convalescent 
phase samples=No. of samples posibive/No. of samples toted.
Table 2
Percent homology of CHIK-Kadapa strain (GQ119362) with different CHIKV isolates at nucleotide and amino acid level
Isolates/Strains
Percent homology with “CHIK-Kadapa” Strain(GQ119362)
Nucleotide level Amino acid level
Present  study strains 99.63依 0.29 99.50依 0.58
Central/East/South African isolates(CESA) 99.23依0.52 100.00依0.00*
Asian isolates 95.18依1.89 97.40依1.26
West African isolates 90.83依7.10 98.30依1.53
* Showed 100% homology, Data are expressed as mean依SD, present study strains include: [GQ119363 (CHIK- Kamalapuram) GQ119364 
(CHIK-Kattaguttapalli) FJ225403 (CHIK-AP-KDP)] .
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Figure 4. Alignment of the deduced amino acids of CHIKV E1 gene 
sequences of the present study strains with the reported CHIKV 
genotypes. 
Non synonymous mutations S168L and D183V are highlighted in 
shaded colour. The present study strains are represented within 
the Boxes.(AF369024:CHIKV Reference strain); (EF027139, 
GU189061, FJ000069, AM25899, DQ443544: Central East South 
African genotype); (AF192901, AF192897: Asian Genotype); 
(AF192891,AF192892: West African Genotype).      
4. Discussion 
  In India CHIKV epidemic was first reported in 1963 and 
in Andhra pradesh the CHIKV epidemic was first reported 
during 1965 in Vishakapatnam, Rajmundry and Kakinada. 
After a time lapse of 40 years, Andhra Pradesh reported 
CHIKV epidemic during 2005. Twenty three districts were 
affected and nearly 77 533 CHIKV cases were suspected by 
the end of 2006[25]. In a recent study it was estimated that the 
burden of Chikungunya for Kadapa district was 160 DALYs (Cost: 
US$ 290 000) and 6 600 DALYs (Cost: US$ 12 400 000) for the state 
of Andhra Pradesh[26]. CHIK cases have been reported from 
Anantapur, Chittoor, Guntur, Kadapa, Kurnool, Nalgonda 
and Prakasam districts of Andhra Pradesh[9,11,19,27,28]. CHIK 
cases were also reported from Tirupati, Hyderabad and 
Secunderabad[11,12,20,29-31]. By the end of 2007 CHIKV cases 
were almost declined and it was thought that the CHIK fever 
was subsided. CHIKV type fever cases were reported in some 
PHC during 2008 in Kadapa district of Andhra Pradesh. 
The focus of the present study was to carry out a thorough 
survey of the regions having CHIKV suspected fever and 
characterize the causative agent. Early detection of CHIKV is 
an essential prerequisite for effective control and prevention 
of the epidemic and RT-PCR using the primer pair 
DVRChk-F/DVRChk-R served as a valuable tool for CHIKV 
detection in the present study as well as in earlier studies 
in Andhra Pradesh, India and Southern Thailand[8,11,20,32]. 
The circulating CHIKV genotype was identified to be of CESA 
origin. 
  The primary sequence of CHIKV E1 glycoprotein is quite 
similar to the E1 fusion protein of SFV and hence it is likely 
that the 3-D folding of these related proteins is similar [1]. In 
a recent study, Homology based model of CHIKV E1 protein 
was constructed using glycoprotein E1 from Semiliki Forest 
Virus as a template[33]. In alphaviruses E1 is responsible for 
cell fusion and E2 is mainly involved in receptor binding and 
cell entry[34]. Domains I and II of the E1 protein are involved 
in E1 trimerization during the viral fusion process. Domain II 
mediates the E1-E2 interactions during the virus maturation 
and budding from infected cells[33]. C503T Nucleotide 
change in CHIK-AP-KDP strain (FJ225403) resulted in a non 
synonymous mutation (S168L) wherein Serine (hydrophobic 
amino acid) was replaced by leucine (hydrophilic amino 
acid). Similarly A548T change in CHIK-Kattaguttapalli strain 
(GQ119364) resulted in non synonymous mutation (D183V) 
wherein aspartic acid (hydrophilic amino acid) was replaced 
by valine(hydrophobic aminoacid). The amino acid changes 
observed in the present study strains (S168L & D183V) are 
non conservative and which might affect the mobility and 
strength of E1-E1 and E1-E2 interactions. 
  In conclusion our 14-month survey revealed the 
circulation of CHIKV in 2008-2009 in Andhra Pradesh 
and the causative agent is identified to be of Central East 
South African (CESA) origin. We observed that in spite 
of the proper guidelines framed by the concerned health 
authorities, CHIKV infections has been underreported due 
to similarity in symptoms with other arboviral diseases(like 
dengue) and  due to lack of adequate facilities for proper 
disease diagnosis. It is quite necessary for the physician’s 
to diagnose the disease properly and provide proper 
medications to the patients. At the same time surveillance 
of the disease should be intensified so as to prevent the 
outbreaks in the near future.  The movement of viremic 
individuals in other cohorts may play an important role in 
spread of CHIKV. However, this cannot be controlled and 
hence a better mosquito control adoption measures would 
play a pivotal role in restricting the magnitude of CHIKV 
outbreaks. 
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Table 3 
Nucleotide and amino acid changes observed in CHIKV strains of the present study.
Genbank
(Accession No.)
Isolate/Strain
E1 nucleotide position E1 protein position
306 384 402 495 503 519 531 548 552 555 168 183
AF369024 Reference strain A C C A C T C A T C S D
*FJ225403 CHIK-AP-KDP G T - T T C T - C T L -
*GQ119362 CHIK-Kadapa G T - T - C T - C T - -
*GQ119363 CHIK-Kamalapuram G T T - - C T - C T - -
*GQ119364 CHIK-Kattaguttapalli G T - T - C T T C T - V
*Present study strains, Letters in BOLD indicate changes leading to non synonymous mutations. 
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